182 related articles for article (PubMed ID: 13679624)
1. Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases.
Satoh K; Muramoto T; Tanaka T; Kitamoto N; Ironside JW; Nagashima K; Yamada M; Sato T; Mohri S; Kitamoto T
J Gen Virol; 2003 Oct; 84(Pt 10):2885-2893. PubMed ID: 13679624
[TBL] [Abstract][Full Text] [Related]
2. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.
Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T
Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132
[TBL] [Abstract][Full Text] [Related]
3. A traceback phenomenon can reveal the origin of prion infection.
Kobayashi A; Asano M; Mohri S; Kitamoto T
Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
[TBL] [Abstract][Full Text] [Related]
4. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.
Yamada M; Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Kitamoto T; Sato T; Nakamura Y; Mizusawa H
Neuropathology; 2009 Oct; 29(5):609-18. PubMed ID: 19659940
[TBL] [Abstract][Full Text] [Related]
5. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.
Cali I; Miller CJ; Parisi JE; Geschwind MD; Gambetti P; Schonberger LB
Acta Neuropathol Commun; 2015 Jun; 3():37. PubMed ID: 26108478
[TBL] [Abstract][Full Text] [Related]
6. Unique clinicopathological features and PrP profiles in the first autopsied case of dura mater graft-associated Creutzfeldt-Jakob disease with codon 219 lysine allele observed in Japanese population.
Ikawa M; Yoneda M; Matsunaga A; Nakagawa H; Kazama-Suzuki A; Miyashita N; Naiki H; Kitamoto T; Kuriyama M
J Neurol Sci; 2009 Oct; 285(1-2):265-7. PubMed ID: 19666177
[TBL] [Abstract][Full Text] [Related]
7. Autopsied case of non-plaque-type dura mater graft-associated Creutzfeldt-Jakob disease presenting with extensive amyloid-β deposition.
Iwasaki Y; Imamura K; Iwai K; Kobayashi Y; Akagi A; Mimuro M; Miyahara H; Kitamoto T; Yoshida M
Neuropathology; 2018 Oct; 38(5):549-556. PubMed ID: 30084170
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
[TBL] [Abstract][Full Text] [Related]
9. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
[TBL] [Abstract][Full Text] [Related]
10. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan.
Hamaguchi T; Sakai K; Noguchi-Shinohara M; Nozaki I; Takumi I; Sanjo N; Sadakane A; Nakamura Y; Kitamoto T; Saito N; Mizusawa H; Yamada M
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1171-5. PubMed ID: 23595947
[TBL] [Abstract][Full Text] [Related]
11. Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes.
Zanusso G; Farinazzo A; Prelli F; Fiorini M; Gelati M; Ferrari S; Righetti PG; Rizzuto N; Frangione B; Monaco S
J Biol Chem; 2004 Sep; 279(37):38936-42. PubMed ID: 15247220
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease.
Ishida C; Okino S; Kitamoto T; Yamada M
J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):325-9. PubMed ID: 15716520
[TBL] [Abstract][Full Text] [Related]
13. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.
Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW
Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease.
Polymenidou M; Stoeck K; Glatzel M; Vey M; Bellon A; Aguzzi A
Lancet Neurol; 2005 Dec; 4(12):805-14. PubMed ID: 16297838
[TBL] [Abstract][Full Text] [Related]
15. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification.
Parchi P; Strammiello R; Notari S; Giese A; Langeveld JP; Ladogana A; Zerr I; Roncaroli F; Cras P; Ghetti B; Pocchiari M; Kretzschmar H; Capellari S
Acta Neuropathol; 2009 Nov; 118(5):659-71. PubMed ID: 19718500
[TBL] [Abstract][Full Text] [Related]
16. Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.
Kobayashi A; Matsuura Y; Mohri S; Kitamoto T
Acta Neuropathol Commun; 2014 Mar; 2():32. PubMed ID: 24685293
[TBL] [Abstract][Full Text] [Related]
17. Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion.
Honda H; Sasaki K; Minaki H; Masui K; Suzuki SO; Doh-Ura K; Iwaki T
Neuropathology; 2012 Apr; 32(2):124-32. PubMed ID: 21801238
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
[TBL] [Abstract][Full Text] [Related]
19. Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease.
Notari S; Strammiello R; Capellari S; Giese A; Cescatti M; Grassi J; Ghetti B; Langeveld JP; Zou WQ; Gambetti P; Kretzschmar HA; Parchi P
J Biol Chem; 2008 Nov; 283(45):30557-65. PubMed ID: 18753138
[TBL] [Abstract][Full Text] [Related]
20. Dura mater graft-associated Creutzfeldt-Jakob disease with 30-year incubation period.
Shijo M; Honda H; Koyama S; Ishitsuka K; Maeda K; Kuroda J; Tanii M; Kitazono T; Iwaki T
Neuropathology; 2017 Jun; 37(3):275-281. PubMed ID: 27925304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
